Press Release


New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials
Mar 03, 2017 14:00 JST
Frost & Sullivan released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific specialist CRO Novotech. Research from the new white paper revealed Asia is quickly becoming a clinical research powerhouse.
More info..

Fast-Evolving US Cardiac Ablation Industry Affords Multiplying Niche Opportunities, Says Frost & Sullivan
Jun 25, 2014 10:45 JST
Recent analysis from Frost & Sullivan's Analysis of the US Cardiac Ablation Market finds the market earned revenue of $2.77 billion in 2013 and estimates this to reach $5.75 billion in 2020. The analysis covers catheter ablation, surgical ablation and cardiac mapping.
More info..

Latest Release


More Latest Release >>